Cargando…
Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity
Antibodies recognizing complexes of the chemokine platelet factor 4 (PF4/CXCL4) and polyanions (P) opsonize PF4-coated bacteria hereby mediating bacterial host defense. A subset of these antibodies may activate platelets after binding to PF4/heparin complexes, causing the prothrombotic adverse drug...
Autores principales: | Nguyen, Thi-Huong, Medvedev, Nikolay, Delcea, Mihaela, Greinacher, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458132/ https://www.ncbi.nlm.nih.gov/pubmed/28530237 http://dx.doi.org/10.1038/ncomms14945 |
Ejemplares similares
-
Rupture Forces among Human Blood Platelets at different Degrees of Activation
por: Nguyen, Thi-Huong, et al.
Publicado: (2016) -
Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins
por: Nguyen, Thi-Huong, et al.
Publicado: (2019) -
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Thiele, Thomas, et al.
Publicado: (2021) -
Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021) -
Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
por: Noikongdee, Phichchapha, et al.
Publicado: (2021)